Early Identification of Fragile X Syndrome through Expanded Newborn Screening

Area of Science:

• Genetics
• Developmental Pediatrics
• Public Health

Background:

• Fragile X syndrome (FXS) research has advanced understanding but diagnosis remains delayed.
• Current average age of FXS diagnosis is 3 years, hindering early intervention.
• Interventions for FXS are most effective when initiated shortly after birth.

Purpose of the Study:

• To evaluate the feasibility and impact of newborn screening for fragile X syndrome.
• To address barriers preventing FXS inclusion in standard newborn screening panels.
• To gather data on recruitment, enrollment, testing, and follow-up for FXS newborn screening.

Main Methods:

• Implementation of a voluntary, research-based newborn screening program for FXS called Early Check in North Carolina.
• Addressing challenges identified in previous pilot studies.
• Ongoing data collection on program logistics and outcomes.

Main Results:

• The Early Check program is actively collecting data on the implementation of voluntary FXS newborn screening.
• Insights are being gained into the practicalities of screening, including recruitment and lab testing.
• The program aims to demonstrate the feasibility and potential impact of early FXS detection.

Conclusions:

• Early Check offers a novel approach to facilitate earlier identification of fragile X syndrome through newborn screening.
• The program provides a platform for continued research into the benefits of early FXS diagnosis and intervention.
• Addressing current barriers is key to integrating FXS screening into routine newborn care.